[1] Vucak J, Turudic D, Milosevic D, et al. Genotype-phenotype correlation of β‐thalassemia in croatian patients: a specific HBB gene mutations. J Pediatr Hematol/Oncol, 2018; 40, e77−82. doi:  10.1097/MPH.0000000000001039
[2] Kattamis A, Forni GL, Aydinok Y, et al. Changing patterns in the epidemiology of β‐thalassemia. Eur J Haematol, 2020; 105, 692−703. doi:  10.1111/ejh.13512
[3] Bonifazi F, Conte R, Baiardi P, et al. Pattern of complications and burden of disease in patients affected by beta thalassemia major. Curr Med Res Opin, 2017; 33, 1525−33. doi:  10.1080/03007995.2017.1326890
[4] Lai KT, Huang GF, Su L, et al. The prevalence of thalassemia in mainland China: evidence from epidemiological surveys. Sci Rep, 2017; 7, 920. doi:  10.1038/s41598-017-00967-2
[5] Bajwa H, Basit H. Thalassemia. Treasure Island (FL): StatPearls Publishing. 2020.
[6] Luo HY, Chui DHK. Diverse hematological phenotypes of β‐thalassemia carriers. Ann N Y Acad Sci, 2016; 1368, 49−55. doi:  10.1111/nyas.13056
[7] He S, Li JH, Li DM, et al. Molecular characterization of α- and β‐thalassemia in the Yulin region of Southern China. Gene, 2018; 655, 61−4. doi:  10.1016/j.gene.2018.02.058
[8] Xu LP, Huang HL, Wang Y, et al. Molecular epidemiological analysis of α- and β‐thalassemia in Fujian province. Chin J Med Genet, 2013; 30, 403−6. (In Chinese
[9] Sirichotiyakul S, Maneerat J, Sa-nguansermsri T, et al. Sensitivity and specificity of mean corpuscular volume testing for screening for α-thalassemia-1 and β‐thalassemia traits. J Obstet Gynaecol Res, 2005; 31, 198−201. doi:  10.1111/j.1447-0756.2005.00280.x
[10] Mirzakhani M, Tarrahi MJ, Baghersad A, et al. Can couples with MCV≥80, MCH< 26, HbA2< 3.2, HbF< 3 be classified as low-risk β-thalassemia group? J Pediatr Hematol Oncol, 2019; 41, 303−6. doi:  10.1097/MPH.0000000000001423
[11] Karnpean R, Pansuwan A, Fucharoen G, et al. Evaluation of the URIT-2900 automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations. Clin Biochem, 2011; 44, 889−93. doi:  10.1016/j.clinbiochem.2011.04.009
[12] Jamnok J, Sanchaisuriya K, Chaitriphop C, et al. A new indicator derived from reticulocyte hemoglobin content for screening iron deficiency in an area prevalent for thalassemia. Lab Med, 2020; 51, 498−506. doi:  10.1093/labmed/lmz099